Background Patients with coronavirus disaese 2019 (COVID-19) can develop a cytokine
release syndrome that eventually leads to acute respiratory distress syndrome requiring …

SARS-CoV-2 is responsible for the development of coronavirus disease 2019 (COVID-19)
in infected individuals, who can either exhibit mild symptoms or progress toward a life-…

The SARS-CoV-2 is responsible for the pandemic COVID-19 in infected individuals, who
can either exhibit mild symptoms or progress towards a life-threatening acute respiratory …

SARS‐CoV‐2 infection causes an abrupt response by the host immune system, which is largely
responsible for the outcome of COVID‐19. We investigated whether the specific immune …

COVID-19 has overloaded national health services worldwide. Thus, early identification of
patients at risk of poor outcomes is critical. Our objective was to analyse SARS-CoV-2 RNA …

Increased recruitment of transitional and non-classical monocytes in the lung during SARS-CoV-2
infection is associated with COVID-19 severity. However, whether specific innate …

B and T cell responses were evaluated in patients with rheumatoid arthritis (RA) or psoriatic
arthritis (PsA) after 1 or 2 weeks of methotrexate (MTX) withdrawal following each COVID-19 …

The impact of the newly discovered severe acute respiratory syndrome coronavirus 2
causing coronavirus disease‐19 (COVID‐19) in hemodialysis patients remains poorly …

Tertiary lymphoid structures (TLSs) are clusters of lymphoid cells with an organization that
resembles that of secondary lymphoid organs. Both structures share common developmental …

The immune response promoted by SARS-CoV-2 vaccination is relevant to develop novel
vaccines and optimized prevention strategies. We analyzed the adaptive immunity in healthy …